Evidence map›Paper›PMID 37049956›Full record

ArticleMolecules (Basel, Switzerland)2023

Encapsulation of

Yasmine Chakroun, Youssef Snoussi, Mohamed M Chehimi, Manef Abderrabba, Jean-Michel Savoie, Souheib Oueslati

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Ethnomedicinal uses, phytochemistry, and biological properties ofJournal of traditional and complementary medicine · 2026
    Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Yasmine ChakrounINRAE, UR1264 MycSA, CS2032, 33882 Villenave d'Ornon, France.ORCID 0000-0003-2065-2519
Youssef SnoussiIPEST, Laboratory Molecules Materials and Applications (LMMA), University of Carthage, La Marsa, Tunis 2070, Tunisia.
Mohamed M ChehimiCNRS, UMR 7182 ICMPE, 2-8 Rue Henri Dunant, 94320 Thiais, France.ORCID 0000-0002-6098-983X
Manef AbderrabbaIPEST, Laboratory Molecules Materials and Applications (LMMA), University of Carthage, La Marsa, Tunis 2070, Tunisia.
Jean-Michel SavoieINRAE, UR1264 MycSA, CS2032, 33882 Villenave d'Ornon, France.ORCID 0000-0002-1427-0293
Souheib OueslatiIPEST, Laboratory Molecules Materials and Applications (LMMA), University of Carthage, La Marsa, Tunis 2070, Tunisia.ORCID 0000-0001-9396-4690
Tunis University · TNCentre National de la Recherche Scientifique · FRInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRUniversity of Carthage · TN

Funding

Campus France 39198RKCMCU 18G0913
6 · The paper itself

Abstract

Essential oils (EOs) that have antifungal activity and mycotoxin reduction ability are candidates to develop bioactive alternatives and environmentally friendly treatment against Fusarium species in cereals. However, their practical use is facing limitations such as high volatility, UV sensitivity, and fast oxidation. Encapsulation techniques are supposed to provide protection to the EOs and control their release into the environment.

Indexed as

ChitosanFusariumMycotoxinsOils, VolatileAntifungal AgentsDepsipeptidesSilicon DioxideAntifungal AgentsChitosanDepsipeptidesenniatinsMycotoxinsOils, VolatileSilicon Dioxideantifungal activitychitosanenniatinsessential oilFusariummycotoxinsnanoencapsulation

Identifiers

PMID37049956
PMCPMC10096032
OpenAlexW4362560493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.